Index by author

February 01, 2024; Volume 91,Issue 2

  1. Lyou, Jason

    1. Hypertension and severe hyperreninemia in a young man
      Joshua M. Leisring, MD, Jason Lyou, MD, Eshetu Obole, MD and Amy A. Yau, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 103-108; DOI: https://doi.org/10.3949/ccjm.91a.23055

      A 29-year-old man with blood pressure measurements of 152/118 mm Hg and 156/116 mm Hg at 2 separate clinic visits is started on combination antihypertensive therapy and undergoes evaluation for secondary causes of hypertension.

  2. Mandell, Brian F.

    1. Dealing with the “T” (testosterone)
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 78-79; DOI: https://doi.org/10.3949/ccjm.91b.02024

      If a patient feels better when taking testosterone supplementation, is it the “T” or is it a placebo effect?

    2. Our Peer-Reviewers for 2023
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 85;

  3. Modarressi, Taher

    1. Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
      Taher Modarressi, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 82; DOI: https://doi.org/10.3949/ccjm.91c.02001

  4. Obole, Eshetu

    1. Hypertension and severe hyperreninemia in a young man
      Joshua M. Leisring, MD, Jason Lyou, MD, Eshetu Obole, MD and Amy A. Yau, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 103-108; DOI: https://doi.org/10.3949/ccjm.91a.23055

      A 29-year-old man with blood pressure measurements of 152/118 mm Hg and 156/116 mm Hg at 2 separate clinic visits is started on combination antihypertensive therapy and undergoes evaluation for secondary causes of hypertension.

  5. Plante, Marie M.

    1. What are the management considerations for venous thromboembolic events in patients with cirrhosis?
      Marie M. Plante, MD, BSN, RN, Emily B. Wolf, MD and Razvan M. Chirila, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 86-88; DOI: https://doi.org/10.3949/ccjm.91a.23045

      The authors review the current evidence on venous thromboembolic event (VTE) risk prediction in patients with cirrhosis, as well as VTE prophylaxis and anticoagulant therapy.

  6. Prasad, Megha

    1. In Reply: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
      Pooja Prasad, MD and Megha Prasad, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 82-83; DOI: https://doi.org/10.3949/ccjm.91c.02002

  7. Prasad, Pooja

    1. In Reply: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
      Pooja Prasad, MD and Megha Prasad, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 82-83; DOI: https://doi.org/10.3949/ccjm.91c.02002

  8. Riley, David

    1. von Willebrand disease: A guide for the internist
      Varinder Kaur, MD, Omar Elghawy, MD, Saarang Deshpande, MD and David Riley, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 119-127; DOI: https://doi.org/10.3949/ccjm.91a.22033

      The pathophysiology of von Willebrand disease, its subtypes, common presentations of each subtype, diagnostic testing, and management of clinical manifestations of the disease are reviewed.

  9. Roth, Bradley

    1. Does my patient have testosterone deficiency?
      Andrew D. Shumaker, MD, Navid Leelani, DO, Bradley Roth, Prajit Khooblall, MD, Raevti Bole, MD, Scott D. Lundy, MD, PhD and Petar Bajic, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 93-95; DOI: https://doi.org/10.3949/ccjm.91a.23064

      Diagnosis of testosterone deficiency requires the presence of relevant signs or symptoms along with biochemical evidence.

  10. Shumaker, Andrew D.

    1. Does my patient have testosterone deficiency?
      Andrew D. Shumaker, MD, Navid Leelani, DO, Bradley Roth, Prajit Khooblall, MD, Raevti Bole, MD, Scott D. Lundy, MD, PhD and Petar Bajic, MD
      Cleveland Clinic Journal of Medicine February 2024, 91 (2) 93-95; DOI: https://doi.org/10.3949/ccjm.91a.23064

      Diagnosis of testosterone deficiency requires the presence of relevant signs or symptoms along with biochemical evidence.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue